Ready for your all-in-one single cell sequencing solution?

Singleron Biotechnologies is an innovative and rapidly growing company providing complete solutions for single cell sequencing technologies. To improve clinical diagnosis, drug development, and health management, Singleron brings breakthrough single cell analysis techniques to clinicians and researchers.

Management Team

Nan Fang, PhD, MBA; CEO and Founder

Dr. Fang has over a decade of expertise in product development, commercialization, team management, and corporate strategy. She draws her expertise from previous roles as Deputy GM at Novogene and leading to the successful launch of 30+ products at QIAGEN. Recognitions: Forbes CN top 50 women.

Andreas Schmidt, PhD; SVP, Head of Global BD

As a seasoned biotech entrepreneur and former Proteona CEO, Dr. Schmidt brings a wealth of experience, having led AYOXXA Biosystems for 7 years. He served on boards of multiple biotech firms and provided advisory support to research institutes incl. EIT, Duke-NUS Medical School, SMART, and Scaler8.

Jonathan Scolnick, PhD; General Manager, Singapore

With 20+ years in R&D Dr. Scolnick’s expertise spans academia and clinical services companies like Natera and Nugen Technologies. As the former Co-founder and CSO at Proteona, he led the development of wet and dry lab tools for single-cell tech. to predict patient responses to drugs.

Jing Zhou, PhD; CSO and General Manager, US

Dr. Zhou has a decade of expertise in mechanical engineering, electronic technology, materials science, biotechnology, and stem cells. Before co-founding Singleron, she served as a Patent Agent at Dilworth IP LLC. She advised the CEO of IsoPlexis Inc. and was Associate Research Scientist at Yale.

Yifeng Gao, CFO

Gao was senior manager in the audit and assurance section of Deloitte Touche Tohmatsu. Mr. Gao held various roles at Baixing Co., Ltd., including CFO and director. He also served as CFO of Frontage Holdings Group, successfully leading its IPO in 2019.

Jue Fan, PhD; SVP, Global Head of Bioinformatics and Data Science

Dr. Fan served as CTO at IsoTex and worked as a Bioinformatician at Cellular Research Inc. and later as a Bioinformatics Manager at BD (Beckton Dickson Inc., USA).

Xiaoyuan Zi, PhD; SVP, Global Head of Clinical Development

Dr. Zi was Executive Director of Urology Laboratory at Shanghai Changhai Hospital, responsible for precision medicine research for prostate cancer. Dr. Zi is currently a member and secretary of the Medical Cell Biology Sub-Committee of Chinese Medical Association.

Scientific Advisory Board

Prof. Dr. Reinhard Buettner, MD; University of Cologne, Germany

Dr. Buettner, a leading pathologist, has pioneered NGS and breakthrough technologies in clinical applications. He serves on the boards of LNS, Luxembourg, and the German Cancer Aid, and is the Founding President of the Vladimir Totovic Foundation/German Pathology.

Fei Sun, MD PhD; Dean, Nantong University, China

Dr. Sun, an esteemed expert in Reproductive Biology and Medicine. Recognized for outstanding research, he received numerous awards, including the Canadian Fertility and Andrology Society Best Basic Science Research Paper (2004), and Chief scientist of National 973 program.

Gary Koretzky, MD., PhD; Vice Provost, Cornell University

Dr. Koretzky is a globally recognized immunologist and significantly contributed to the understanding of immune system cell development. He holds fellowships with the American Academy of Arts and Sciences, American Association for the Advancement of Science.

Dirk Loeffert, PhD; Co-founder and CEO, BioMillenia

Dr. Loeffert is a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialization. Previously, he was Vice President of Product Development at QIAGEN, in charge of all product development activities of the Life Sciences Business Area.

Rong Fan, Co-Founder of Singleron, Professor Yale University

Dr. Fan is an expert in cutting-edge single-cell micro/nano-technologies, investigating cellular heterogeneity and inter-cellular signaling networks in health and disease. He co-founded IsoPlexis, creator of IsoCode technology, ranked #1 in 2017 Top 10 Innovations.

Board of Directors

Nan Fang, PhD, MBA; CEO and Founder

Dr. Fang has over a decade of expertise in product development, commercialization, team management, and corporate strategy. She draws her expertise from previous roles as Deputy GM at Novogene and leading to the successful launch of 30+ products at QIAGEN. Recognitions: Forbes CN top 50 women.

Jing Zhou, PhD; CSO and General Manager, US

Dr. Zhou has a decade of expertise in mechanical engineering, electronic technology, materials science, biotechnology, and stem cells. Before co-founding Singleron, she served as a Patent Agent at Dilworth IP LLC. She advised the CEO of IsoPlexis Inc. and was Associate Research Scientist at Yale.

Yifeng Gao, CFO

Gao was senior manager in the audit and assurance section of Deloitte Touche Tohmatsu. Mr. Gao held various roles at Baixing Co., Ltd., including CFO and director. He also served as CFO of Frontage Holdings Group, successfully leading its IPO in 2019.

Qun Zhao; Partner, Oriza Seed

Prior to joining Oriza Seed, Mr. Zhao had 14 years of experience in the pharmaceutical industry. Besides VC fund for early-stage companies, Mr. Zhao managed M&A investment funds of public company and PE fund. he was investor and board member of Ascentage Pharma, CSTONE Pharmaceuticals and others.

Yun Gao, MBA; VP, Lilly Asia Ventures (LAV)

Yun Gao is VP with Lilly Asia Ventures. Prior to that, Yun was Investment Professional at Softbank China Venture Capital (SBCVC). She worked as Associate of Business Development and Corporate Strategy at Medtronic China and Senior Analyst at IMS Consulting Group.

Xiangyu Ouyang; Founder and Managing Partner, Sherpa Healthcare Partners

Before establishing Sherpa Healthcare Partners in 2018, Mr. Ouyang played pivotal roles at Legend Group from 1992, serving as General Manager of Business Development and Business Unit Head of Lenovo. Joining Legend Capital in 2004 as Managing Director, he later founded its healthcare branch.

Jue Fan, PhD; SVP, Global Head of Bioinformatics and Data Science

Dr. Fan served as CTO at IsoTex and worked as a Bioinformatician at Cellular Research Inc. and later as a Bioinformatics Manager at BD (Beckton Dickson Inc., USA).

Want to become part of our team?

Want to become part of our team?

We are always looking for motivated and dedicated candidates. Check out our current open positions and reach out to us.